240 related articles for article (PubMed ID: 24558022)
41. Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.
Koiso T; Yamamoto M; Kawabe T; Watanabe S; Sato Y; Higuchi Y; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):2-10. PubMed ID: 27903177
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
43. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.
Kong DS; Lee JI; Im YS; Nam DH; Park K; Kim JH
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):385-9. PubMed ID: 20097485
[TBL] [Abstract][Full Text] [Related]
44. Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ; Olson JJ; Curran WJ; Shu HG; Crocker IR; Prabhu RS
J Neurooncol; 2017 Feb; 131(3):611-618. PubMed ID: 28000105
[TBL] [Abstract][Full Text] [Related]
45. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
46. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.
Kim DH; Schultheiss TE; Radany EH; Badie B; Pezner RD
J Neurooncol; 2013 Oct; 115(1):37-43. PubMed ID: 23813230
[TBL] [Abstract][Full Text] [Related]
47. Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.
Shultz DB; Modlin LA; Jayachandran P; Von Eyben R; Gibbs IC; Choi CYH; Chang SD; Harsh GR; Li G; Adler JR; Hancock SL; Soltys SG
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):993-999. PubMed ID: 26194677
[TBL] [Abstract][Full Text] [Related]
48. External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
Press RH; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Burri SH; Patel KR; Asher AL; Sumrall AL; Curran WJ; Shu HG; Crocker IR; Prabhu RS
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):632-638. PubMed ID: 28581405
[TBL] [Abstract][Full Text] [Related]
49. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases.
Bernard ME; Wegner RE; Reineman K; Heron DE; Kirkwood J; Burton SA; Mintz AH
J Cancer Res Ther; 2012; 8(2):215-21. PubMed ID: 22842364
[TBL] [Abstract][Full Text] [Related]
50. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
51. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
[TBL] [Abstract][Full Text] [Related]
52. Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With 5 to 15 Brain Metastases.
Hughes RT; McTyre ER; LeCompte M; Cramer CK; Munley MT; Laxton AW; Tatter SB; Ruiz J; Pasche B; Watabe K; Chan MD
Neurosurgery; 2019 Aug; 85(2):257-263. PubMed ID: 29982831
[TBL] [Abstract][Full Text] [Related]
53. The number of prior lines of systemic therapy as a prognostic factor for patients with brain metastases treated with stereotactic radiosurgery: Results of a large single institution retrospective analysis.
Lanier CM; McTyre E; LeCompte M; Cramer CK; Hughes R; Watabe K; Lo HW; O'Neill S; Munley MT; Laxton AW; Tatter SB; Ruiz J; Chan MD
Clin Neurol Neurosurg; 2018 Feb; 165():24-28. PubMed ID: 29289917
[TBL] [Abstract][Full Text] [Related]
54. Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1-4 brain metastases.
Chen Z; Zhou L; Zhao M; Cao K; Li Y; Liu X; Hou Y; Li L; Wang L; Chang L; Yang M; Li W; Xia Y
BMC Cancer; 2022 Sep; 22(1):1010. PubMed ID: 36153515
[TBL] [Abstract][Full Text] [Related]
55. Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.
Mix M; Elmarzouky R; O'Connor T; Plunkett R; Prasad D
J Neurosurg; 2016 Dec; 125(Suppl 1):26-30. PubMed ID: 27903186
[TBL] [Abstract][Full Text] [Related]
56. Gamma Knife radiosurgery to four or more brain metastases in patients without prior intracranial radiation or surgery.
Ojerholm E; Lee JY; Kolker J; Lustig R; Dorsey JF; Alonso-Basanta M
Cancer Med; 2014 Jun; 3(3):565-71. PubMed ID: 24510602
[TBL] [Abstract][Full Text] [Related]
57. Relevance of gamma knife radiosurgery alone for the treatment of non-small cell lung cancer brain metastases.
Zairi F; Ouammou Y; Le Rhun E; Aboukais R; Blond S; Vermandel M; Deken V; Devos P; Reyns N
Clin Neurol Neurosurg; 2014 Oct; 125():87-93. PubMed ID: 25108698
[TBL] [Abstract][Full Text] [Related]
58. Whole brain radiotherapy and stereotactic radiosurgery for patients with recursive partitioning analysis I and lesions <5 cm(3): A matched pair analysis.
Viani GA; Godoi da Silva LB; Viana BS; Rossi BT; Suguikawa E; Zuliani G
J Cancer Res Ther; 2016; 12(2):770-4. PubMed ID: 27461649
[TBL] [Abstract][Full Text] [Related]
59. Patients with Long-Term Control of Systemic Disease Are a Favorable Prognostic Group for Treatment of Brain Metastases with Stereotactic Radiosurgery Alone.
Ebner DK; Gorovets D; Rava P; Cielo D; Kinsella TJ; DiPetrillo TA; Hepel JT
World Neurosurg; 2017 Feb; 98():266-272. PubMed ID: 27838432
[TBL] [Abstract][Full Text] [Related]
60. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases.
Minniti G; Paolini S; D'Andrea G; Lanzetta G; Cicone F; Confaloni V; Bozzao A; Esposito V; Osti M
J Neurooncol; 2017 May; 132(3):455-462. PubMed ID: 28260130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
